Munich-based Ortivity, a company specialised in outpatient orthopaedic care, has received €200M funding led by Apheon, a pan-European private equity investor, with participation from Unigestion and other new investors.
Contentlockr
The transaction will let current Ortivity shareholders partially sell their shares while bringing in new partners, including Unigestion, a private equity firm that focuses on mid-sized companies, along with some new investors from Apheon.
As part of the transaction, Unigestion has acquired a significant minority share, while Apheon will remain the majority owner.
The announcement comes a couple of months after announcing the appointment of Dr. Michael Thorwarth as the new co-CEO.
Ortivity: Specialised in orthopaedic services
Founded in 2022 by a group of leading physicians, Dr. Reinhard Wichels, and Apheon, Ortivity is an integrated outpatient platform for orthopaedic services.
Built on a physician-led model, the company operates over 100 medical centres in Germany and offers a full spectrum of orthopaedic care – from diagnostics, anaesthesia, and surgery to preventive care and aftercare.
Ortivity is experiencing steady growth through a combination of strategic acquisitions and organic development.
Besides funding, Ortivity also announced the appointment of Dr. Michael Thorwarth as the new CEO.
Dr. Michael Thorwarth, newly appointed Co-CEO of Ortivity, adds, “I am delighted that my appointment as CEO coincides with the strengthening of Ortivity’s capital base. This is a significant milestone as we continue to expand our strong network dedicated to innovation in musculoskeletal care. I was impressed by Ortivity’s forward-looking vision—the seamless integration of prevention, diagnostics, and conservative and surgical therapies.”
“I look forward to working closely with our orthopaedic and neurosurgical specialists, as well as our dedicated practice teams, to further develop this model. Together, we aim to set new standards in treatment quality and patient-centred services, creating measurable benefits for our patients,” adds Thorwarth.
Apheon: “Patient and collaborative capital”
Apheon is a pan-European mid-market private equity firm with more than €3B in AuM from select global institutional investors and families.
Known for its “patient and collaborative capital” approach, the Munich-based firm partners with entrepreneurs and management teams, bringing industry expertise to position companies for future growth.
Since its founding in 2005, Apheon has raised more than €3.5B in capital, invested in around 40 companies across Europe, and completed around 200 add-on acquisitions – with an aggregate transaction value of over €7B.
The current portfolio includes 21 companies from target sectors with approximately €3 billion in revenue and more than 20,000 employees.
Nils Lüssem, Partner at Apheon, and Sebastian Walter, Director at Apheon, comment, “We are delighted to welcome Unigestion as a trusted partner. During our search, Unigestion proved to be collaborative, experienced, entrepreneurial, and growth-oriented – we are thrilled to have found such a partner.”
“Since its founding by Apheon and leading physicians, Ortivity has rapidly developed into a leading provider of outpatient orthopaedic care in Germany. The partnership with Unigestion and other selected investors ensures that we have the necessary stable capital to continue our growth and continue investing in first-class patient care,” adds Lüssem.
